The effect of body mass index on short-term outcomes in nonagenarians and centenarians with critical illness: A retrospective cohort study

BACKGROUND: The impact of body mass index (BMI) on morbidity and mortality in very old individuals with acute, critical illness is poorly understood. METHODS: We conducted a bi-national, retrospective, entropy-weighted cohort study of 12,510 nonagenarians and centenarians admitted to the intensive care unit (ICU) over a 15-year period. Based on their admission BMI, patients were classified as underweight (BMI < 20 kg/m²), normal weight (20 kg/m² ≤ BMI < 25.0 kg/m²), overweight (25.0 kg/m² ≤ BMI < 30 kg/m²), or obese (BMI ≥ 30 kg/m²). We estimated the association between admission BMI and clinical outcomes, with in-hospital mortality as the primary outcome. RESULTS: The median BMI of the cohort was 24.4 kg/m² (IQR 21.8-27.5). Of the 12,510 eligible patients, 5,471 (43.7%) were categorized as normal weight, 1,526 (12.2%) underweight, 3,914 (31.3%) overweight, and 1,599 (12.8%) obese. After entropy weighting, increasing BMI was negatively associated with mortality (P < 0.001). In-hospital mortality occurred in 699 (12.8%) normal weight, 223 (14.6%) underweight (relative risk [RR] 1.18; 95% CI 1.02-1.36; P = 0.030), 504 (12.9%) overweight (RR 0.97; 95% CI 0.87-1.08; P = 0.580), and 172 (10.8%) obese (RR 0.76; 95% CI 0.64-0.90; P = 0.001) patients. BMI was not associated with binary requirements for inotropes, invasive ventilation, or renal replacement therapy. CONCLUSIONS: In nonagenarians and centenarians admitted to the ICU, higher BMI was linked to lower in-hospital mortality, suggesting a protective effect. These results emphasize the need for individualized risk assessment in older ICU patients. AUSTRALIAN NEW ZEALAND CLINICAL TRIALS REGISTRY NUMBER: ACTRN12625000297426.